My interest in the problem of the role of viruses in chronic obstructive respiratory disease (CORD) of man is as a virologist and epidemiologist rather than as a specialist in CORD. Hence, my presentation will take the form of speculations made in a state of at least partial ignorance of past and current studies of CORD. My hope is that, uninhibited as I am by "knowledge" as to what cannot be done, I may have some advantage over workers now fully immersed in the problem. These speculations will be concerned with two somewhat different problems.
The first has to do with mechanisms by which viruses might play a role. Hopefully, identification of these may suggest approaches to development of animal models. The second relates to means by which viral contributions to human disease might be detected, some of which I am sure, are currently being explored. An important question is whether additional efforts to collect information and specimens relevant to human disease should be encouraged now.
Viral roles in etiology and pathogenesis
I should like to begin by considering the more general problem of how infectious agents can contribute to the pathogenesis of chronic and degenerative diseases. It seems necessary first to state one perhaps obvious point relating to the word etiology. While, for any given disease an infectious agent such as the tubercle bacillus may be the etiologic agent, for many chronic diseases the relation, if any, of infectious agents may be quite different-preparatory, contributory, or provoking and perhaps relatively nonspecific. Even when the etiologic agent can be identified, its potential for disease usually is influenced significantly by other factors. Thus, I would prefer to speak not of the possible viral etiology of chronic diseases but, rather, of the possible contribution of viruses to the etiology and pathogenesis of such diseases.
Almost by definition, the pathogenesis of chronic and degenerative diseases must evolve slowly over a relatively long period. If an infectious agent (a virus) is to function as the etiologic agent, one can stipulate that it must do so by one or another of three general mechanisms. First, it may during * Professor of Preventive Medicine. a brief period of infection trigger in the host some irreversible, progressive process that culminates in the chronic disease. In effect, this appears to be the case with the known tumor viruses of animals, although the RNA tumor viruses persist patently in the host indefinitely. Other mechanisms which do not involve continued presence of the agent or renewed contact are difficult to conceive. The most evident is some form of autoimmune process. DNA viruses (including many human adenoviruses) that are oncogenic in animals, as one consequence of the incorporation of viral material in the cellular genome, induce the formation of new cellular antigens (T antigens) to which the host responds immunologically.' Such a mechanism has been suggested2 as one way in which viruses might contribute to chronic progressive disease of the central nervous system. Evidence for other mechanisms by which viruses might initiate an autoimmune process has been reviewed in detail by Isacsont with special emphasis on myxoviruses. Those myxoviruses (and bacteria) which possess the enzyme neurominidase do unmask new host antigens (unfortunately, also called T antigens) on surfaces of erythrocytes and possibly other host cells and these induce the formation of specific autoantibodies (T agglutinins). However, the process is acute and, except for possible but rare hemolytic anemia, has no known adverse effect on the host. Cytopathic viruses, affecting tissues or organs normally separated from the host immunologic apparatus, could release tissue-specific antigens into the circulation which might be regarded as foreign and lead to immune response. Such a mechanism may underly postinfectious encephalomyelitis or thyroiditis. However, although leading to long persisting or permanent sequella, these ordinarily are relatively acute in evolution and not chronically progressive.
Second, the agent may establish a long persisting relation with the host, in latent or patent form, at the cellular (or possibly tissue) level. Viruses (also bedsonia and rickettsiae) afford many known or Of viruses known to infect the human respiratory tract, the adenovirus group has been shown to establish long persisting infection with periodic recrudescent shedding in both respiratory and fecal specimens.9 These observations so far have been made only in young children and do not appear to be associated with evident disease.10 Some other examples of viral persistence are unassociated with disease (lymphocytic choriomeningitis virus in congenitally infected mice, serum hepatitis virus in healthy carrier donors), or associated only with acute, nonprogressive disease episodes (fever blisters due to herpes simplex virus, herpes zoster due to varicella virus, Brill's disease due to R. prowazeki). The cases of congenital infection in man with rubella or cytomegaloviruses stand as possible exceptions.
The third general stiuation wherein an infectious agent might act as the etiologic agent in progressive chronic disease would be when it established repeated, effective contact over a long period, each time renewing the stimulus to progress of pathogenesis. Because of immunologic specificity which might result in specific resistance to re-infection, "agent" in this case might well constitute a group of antigenically distinguishable but biologically similar agents. In this case pathogenesis could progress either by means of cumulative tissue destruction and scarring resulting from the acute effects of successive infections or by a hypersensitivity mechanism dependent on common antigens shared by members of groups such as adenoviruses, parainfluenza viruses, or even variant strains of influenza virus A and B. That myxoviruses, at least, can induce hypersensitivity to viral antigen is well established for mumps (dermal hypersensitivity) and is strongly suggested A partial bacterial model of the immunologic mechanism is the effect of repeated infections with B-hemolytic streptococci on progression of rheumatic heart disease. This example differs from the viral model proposed in that the streptococcus possesses an antigen having some similarity to that of heart tissue.1" A possible ex-viral example, adhering more closely to the model, is that of trachoma where it has been postulated that the serious permanent conjunctival scarring is the result of hypersensitivity engendered by repeated re-infections, perhaps including antigenically distinguishable strains of TRIC agents which share a common hypersensitizing antigen.1' This model is particularly appealing with respect to CORD for several reasons. First, it does not necessarily invoke autoimmune response which, for respiratory tissue, is hard to conceive in view of its lack of separation from the immunologic apparatus. Second, the conjunctiva and the respiratory tract mucosal surfaces are superficial sites of infection which are minimally protected against hom6logous reinfection by the classical mechanisms of humoral immunity. And third, the predominant class of antibody in mucous secretions is IgA which does not fix complement. Hence, it would be ineffective in neutralizing any reinfecting agents in cases in which complement might be required. This possibility is perhaps less relevant for viruses than for other microbial agents such as mycoplasma that are known for long persistence.
Reinfections with variant strains of A or B influenza viruses during one lifetime might well number 10 to 20 per type (based on a 2-3 year cycle for A and 4 to 5 years for B and allowing some escapes). Reinfections with RS virus are known to occur"5'1 but how often is unknown. In the case of parainfluenza viruses, homologous reinfection associated with disease also occurs17 but again with undocumented frequency. However, there are three common serotypes (plus two uncommon ones) that have shared antigens, thus perhaps multiplying by three the number of repeated, related stimuli. Respiratory reinfection with adenoviruses may not occur but persistent infection plus successive infections with the 4 or 5 more common serotypes (antigenically related) could provide repeated viral antigenic stimuli. This point perhaps has been overly labored but one final comment is required. Assuming that infection with some or all of these agents does induce hypersensitivity, it may well be that the lifetime number of stimuli by any one antigen (or group of related antigens) is not enough by itself to cause significant disease. However, given hypersensitivity to multiple antigens affecting the same target tissues, their additive separate effects might be sufficient to cause CORD.
The proposition that a virus or other infectious agent plays a collaborative role rather than that of the agent is conceptually simple as stated. Its full development presumably is in the province of those contributors who are discussing synergistic effects. It is possible, for example, that numerous episodes of disease of the lower respiratory tract, due to whatever class of infectious agent, could simply by their collective cumulative tissue damage determine the progressive development of CORD. Important to such development might be the timing (possibly in infancy) and nature (perhaps severe viral bronchiolitis or pertussis) of the initial episode. Alternatively, certain bacteria may be the important agents but with preceding or concurrent viral infections as predisposing factors, an acute example being bacterial pneumonia secondary to influenza or measles. The extent and character of host response to infection also could be influenced by preexisting or concurrent damage of tissues caused by air pollutants including tobacco smoke or inhaled irritant particulate matter, silicosis and tuberculosis providing very specific examples. That at least one noninfectious environmental factor does contribute importantly is evident from the increased risk of CORD attributable to cigarette smoking.18 Thus, a smoking machine, may be a necessary adjunct for any investigator seeking to test an animal model.
Detection of viral contributions
We come now to the problem of how viral contributions to CORD can be detected in man. This is essentially an epidemiologic problem but one that must depend heavily on virologic and immunologic methods of observation. Whatever the role postulated (collaborative or as the etiologic agent), the problem is complicated by the prolonged pathogenesis and evolution of CORD and by the large number of viruses that can and, with varying frequency, do cause lower respiratory tract disease. It is certainly feasible and important to observe closely patients with clearly evident disease, as a number of investigators are now doing, in order to detect new episodes of viral respiratory disease and to determine how each such episode affects the progress of the disease. Such observations are relevant to any hypothesis involving repeated stimuli and, to the extent that the episodes cause measurable progress, they would serve both to support the general hypothesis and to identify the responsible viruses.
Much more difficult, and correspondingly less certain to be productive in the light of our present state of knowledge, would be efforts to test those aspects of the various hypotheses relating to events preceding clinical onset of CORD, including in particular those related to the initiation of the disease process. In the long run, it may well be necessary to set up long con-tinuing longitudinal studies of sizable populations of the Framingham type but, perhaps, beginning with a population of very young age as in our Virus Watch program.9'10'20 Such a study, even if grafted onto some existing comprehensive medical care program, would constitute a massive undertaking and its results would be long in evolving.
The more realistic present alternative is to consider what we can do, given patients with declared CORD for study. Under any given hypothesis, how would we expect such patients to differ from otherwise similar but disease-free persons? As a beginning, the possibility was suggested that viral infection might alter cell antigens. In such event, the affected host should respond immunologically to such antigen in terms of hypersensitivity (basis for disease progression) and, possibly, humoral antibody. Patients whose disease is due to the same virus should possess similarly altered respiratory tissue antigens to which they are hypersensitive and might well possess similarly specific autoantibodies. Assuming the latter, attempts might be made to demonstrate the presence of both antigen and antibody by use of the indirect fluorescent antibody (FA) method, seeking to stain biopsy or autopsy tissue specimens treated with autologous serum. Specimens obtained at autopsy, that had been stained with autologous serum, could be used to explore the presence of antibody in sera from other patients and from healthy persons. Existence of hypersensitivity might be demonstrable by dermal tests using extracts of affected tissue as antigen. Quantitative limitations inherent in acceptable biopsy techniques might restrict or preclude testing patients with autologus antigens but acceptable preparations could be made from autopsy material.
Hypotheses depending on long persistence of a virus in the host have in common the expectation that study of CORD patients should provide evidence of such viral persistence. Studies of this type are, I am sure, currently underway. Presumably, they include study of biopsy and autopsy tissue specimens for the presence of viral antigens, using the FA method, and efforts to recover infectious virus from the same specimens by both inoculation of extracts into cell cultures or other hosts and attempts to unmask latent viruses in tissue cultures prepared from the specimen tissues. While study of serially collected biopsy specimens would be necessary to prove viral persistence, positive results from single specimens obtained in the absence of recent acute disease would lend support to the hypothesis and also again serve to identify candidate responsible viruses. The problem of satisfactory control specimens poses some obvious difficulties which I am sure are recognized by the investigators. Parallel serologic studies would certainly be conducted but might be of limited assistance. Since long viral persistence should result in either continuous or periodic stimulation of antibody production, lack of antibody might exclude the operation of specific viruses in individual cases. Because of the relative ubiquity of the most promising candidate viruses, presence of antibody by itself would have little significance. However, if persistence is associated with continuing active antigenic stimulation, higher than average titers of antibody might be expected as reported for measles in two patients with progressive central nervous system disease. 8 The possibility of detecting hypersensitivity to virus-induced new cellular antigens has been discussed already. While hypersensitivity to normal respiratory tissue antigens has been regarded as improbable (perhaps with inadequate reason), hypersensitivity to viral antigens was invoked in mechanisms involving either long persistence of virus or repeated effective contact. In this light, not only should the histopathology of CORD be compatible with the operation of hypersensitivity (my impression is that it is), but CORD patients might be expected to react positively to dermal tests with suitable preparations of viral antigens. Initially, these probably should be purified suspensions of intact but inactivated viral particles but, assuming significant positive results, preparations containing different viral fractions would become important. Except for mumps,' little is known about the frequency with which viral infections of man induce hypersensitivity to viral antigens. In addition to recent observations with respect to measles,"' hypersensitivity to western equine encephalomyelitis virus has been demonstratedS and it has long been accepted that the "immune" reaction to vaccinia in part reflects hypersensitivity since it can be elicited with noninfective vaccinia virus. Obviously, even less is known about the prevalence of hypersensitivity to individual viruses. If it is a common sequel to infection with ubiquitous viruses, it might prove to be nearly as common in controls as in CORD patients with respect to any given viral antigen. Indeed, the number of antigens eliciting positive response might be the main basis of differentiation. SUMMARY I should like now to summarize briefly. If viruses play the role of the etiologic agent in CORD, they may relate to the host briefly, continuously, or repeatedly. The most reasonable mechanisms for virus-mediated pathogenesis involve either simple cumulative damage due to repeated episodes of acute disease (this implies multiple viruses acting nonspecifically) or some form of hypersensitivity. This latter could be directed either against a virus-induced new cellular antigen or against a tissue-fixed viral antigen. Virus also, obviously, could play a collaborative or synergistic role. For the present, I think studies in man should continue to be focussed on CORD
